The specifics, since they change the answer: 97.9% · PeptideMeter · 97.6% · Janoshik. The comparison I want does not seem to exist anywhere in a form I can evaluate.…
reference-standard
Page 8 of 8 · 179 questions tagged reference-standard.
Setup, so nobody has to ask: 97.1% · Medutest · 99.1% · Janoshik. Both of these get recommended confidently by different people, which suggests neither is obviously…
Details up front: a TFA mobile phase · dulaglutide · a C4 column. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have…
The method section is present, which is unusual enough that I want to make use of it. The claim is plausible, which is exactly why I want to check it. I am able to…
Setup, so nobody has to ask: dulaglutide · a C18 column · tirzepatide. I suspect the honest answer is that it depends, in which case I would like to know on what.…
The case in front of me: survodutide · a C4 column · tirzepatide. These are treated as interchangeable and I do not think they are. If both are acceptable I would…
Concretely: 95.2% · VendorInvestigate · 96.4% · Medutest. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to…
Concretely: 95.2% · VendorInvestigate · 97.9% · Medutest. I would like the axes of comparison first and the recommendation second. I have tried the first option and…
Setup, so nobody has to ask: 99.4% · Medutest · 96.8% · Medutest. Both of these get recommended confidently by different people, which suggests neither is obviously…
Stated plainly: 95.2% · Medutest · 97.1% · Medutest. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
Setup, so nobody has to ask: a formic acid mobile phase · mazdutide · a wide-pore C18 column. The empirical answer seems settled. The explanation does not. If the…